These tumor-specific signatures included the TNBCtype-4 signatures, which define certain clinical and biological features of four TNBC subtypes26,27, and the Intrinsic Basal signature, which was established by comparison across breast cancer subtypes (ER+, HER2+, and TNBC)28. Here, ESR1 is linked to breast carcinoma.